clinical trial · NCT04056481
Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria
Acute Hepatic PorphyriaGivosiran
brief summary
The purpose of this study is to provide expanded access of givosiran to patients with Acute Hepatic Porphyria (AHP).
started
—
primary completion
—
completion
—
last updated
May 20, 2024
detailed description
Choosing to participate in an expanded access program is an important personal decision. Talk with your doctor and family members or friends about deciding to join a research study. To learn more about this study, please have your doctor contact the study research staff using the Contacts provided. For general information, see the link provided in More Information.
official title
Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria (AHP)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol